what is a glp 1 super responder Tell me in the comments if you're responder, slow or non- responder. Hope this explanation helps. 💧💧💧#obesitymedicine #glp1 #glp1forweightloss #glp1medication #obesitydoctor #doctorsofinstagram Obesity Doctor: GLP-1 Super-Responder--Help! (Office

The Overlap Risk: Why Concurrent Use Is Not Recommended The Pharmaceutical Journal (Royal Pharmaceutical Society, December 2025) states that concurrent administration of tirzepatide and semaglutide "could heighten side effects" due to their "overlapping incretin activity." When both drugs are active simultaneously, the GLP-1 receptor faces amplified agonist load

Jensen, M

Notably, prevalence appears to be lower among men with type 1 diabetes (T1D), with reported rates up to 42.5% [11,12]

Most patients see meaningful results within the first 416 weeks

In this episode of Modern Thyroid and Wellness, McCall sits down with Dr

( 10.1038/s42255-020-0209-6) [DOI] [PMC free article] [PubMed] [Google Scholar] Bollag RJ, Zhong Q, Phillips P, Min L, Zhong L, Cameron R, Mulloy AL, Rasmussen H, Qin F, Ding KH, et al